NeoPharm (Daejeon) Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
184
- Stock Symbol
-
092730
- Investments
-
1
- Share Price
-
$16.19
- (As of Friday Closing)
NeoPharm (Daejeon) General Information
Description
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.
Contact Information
Website
www.neopharm.co.krCorporate Office
- 309-8 Techno 2-ro
- Daejeon, Yuseong
- South Korea
Corporate Office
- 309-8 Techno 2-ro
- Daejeon, Yuseong
- South Korea
NeoPharm (Daejeon) Stock Performance
As of 13-Nov-2026, NeoPharm (Daejeon)’s stock price is $16.19. Its current market cap is $253M with 15.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $16.19 | $16.68 | $10.15 - $18.70 | $253M | 15.6M | 62.1K | $1.25 |
NeoPharm (Daejeon) Financials Summary
As of 31-Dec-2025, NeoPharm (Daejeon) has a trailing 12-month revenue of $92.9M.
|
In Thousands, USD |
TTM 31-Dec-2025 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 107,544 | 107,544 | 47,926 | 60,278 |
| Revenue | 92,882 | 92,882 | 87,226 | 74,270 |
| EBITDA | 22,258 | 22,258 | 21,433 | 20,253 |
| Net Income | 19,550 | 19,550 | 16,904 | 17,754 |
| Total Assets | 151,257 | 151,257 | 130,648 | 137,706 |
| Total Debt | 1,330 | 1,330 | 427 | 827 |
NeoPharm (Daejeon) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
NeoPharm (Daejeon) Patents
NeoPharm (Daejeon) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026084206-A1 | Cosmetic composition for inhibiting sebum secretion | Pending | 14-Oct-2024 | ||
| WO-2026084205-A1 | Cosmetic material composition for skin anti-inflammation and skin soothing | Pending | 14-Oct-2024 | ||
| US-20220142888-A1 | Composition for improving skin conditions | Inactive | 11-Nov-2020 | ||
| US-20240082131-A1 | Composition for improving skin conditions | Inactive | 11-Nov-2020 | ||
| US-11607378-B2 | Cosmetic composition comprising amide-based compound | Active | 13-Mar-2020 | A61K8/42 |
NeoPharm (Daejeon) Signals
NeoPharm (Daejeon) Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
NeoPharm (Daejeon) Investments (1)
NeoPharm (Daejeon)’s most recent deal was a Corporate with GPSkin for . The deal was made on 01-Jan-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| GPSkin | 01-Jan-2016 | Corporate | Monitoring Equipment |
NeoPharm (Daejeon) ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Household Products
Industry
Rank
Percentile
Personal Products
Subindustry
Rank
Percentile
NeoPharm (Daejeon) Exits (1)
NeoPharm (Daejeon)’s most recent exit was on 01-Jan-2016 from GPSkin. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| GPSkin | 01-Jan-2016 | Completed |
|
NeoPharm (Daejeon) FAQs
-
When was NeoPharm (Daejeon) founded?
NeoPharm (Daejeon) was founded in 2000.
-
Where is NeoPharm (Daejeon) headquartered?
NeoPharm (Daejeon) is headquartered in Daejeon, South Korea.
-
What is the size of NeoPharm (Daejeon)?
NeoPharm (Daejeon) has 184 total employees.
-
What industry is NeoPharm (Daejeon) in?
NeoPharm (Daejeon)’s primary industry is Personal Products.
-
Is NeoPharm (Daejeon) a private or public company?
NeoPharm (Daejeon) is a Public company.
-
What is NeoPharm (Daejeon)’s stock symbol?
The ticker symbol for NeoPharm (Daejeon) is 092730.
-
What is the current stock price of NeoPharm (Daejeon)?
As of 13-Nov-2026 the stock price of NeoPharm (Daejeon) is $16.19.
-
What is the current market cap of NeoPharm (Daejeon)?
The current market capitalization of NeoPharm (Daejeon) is $253M.
-
What is NeoPharm (Daejeon)’s current revenue?
The trailing twelve month revenue for NeoPharm (Daejeon) is $92.9M.
-
What is NeoPharm (Daejeon)’s annual earnings per share (EPS)?
NeoPharm (Daejeon)’s EPS for 12 months was $1.25.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process